76 results on '"Sławin A"'
Search Results
2. Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration
3. A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
4. Do Margins Matter? The Prognostic Significance of Positive Surgical Margins in Radical Prostatectomy Specimens
5. A Comprehensive Approach Toward Novel Serum Biomarkers for Benign Prostatic Hyperplasia: The MPSA Consortium
6. Plasminogen Activation Inhibitor-1 Improves the Predictive Accuracy of Prostate Cancer Nomograms
7. A Preliminary Study of JM-27: A Serum Marker That Can Specifically Identify Men With Symptomatic Benign Prostatic Hyperplasia
8. Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo
9. EXPRESSION OF SURVIVIN AND APOPTOTIC BIOMARKERS IN BENIGN PROSTATIC HYPERPLASIA
10. DO MARGINS MATTER? THE PROGNOSTIC SIGNIFICANCE OF POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY SPECIMENS
11. Improved Detection of Clinically Significant, Curable Prostate Cancer With Systematic 12-Core Biopsy
12. Six Additional Systematic Lateral Cores Enhance Sextant Biopsy Prediction of Pathological Features at Radical Prostatectomy
13. Assessment of the Enhancement in Predictive Accuracy Provided by Systematic Biopsy in Predicting Outcome for Clinically Localized Prostate Cancer
14. Predictors of Prostate Cancer After Initial Negative Systematic 12 Core Biopsy
15. Predicting the Presence and Side of Extracapsular Extension: A Nomogram for Staging Prostate Cancer
16. VARIATION IN PROSTATE SPECIFIC ANTIGEN RESULTS FROM 2 DIFFERENT ASSAY PLATFORMS: CLINICAL IMPACT ON 2,304 PATIENTS UNDERGOING PROSTATE CANCER SCREENING
17. IS TUMOR VOLUME AN INDEPENDENT PROGNOSTIC FACTOR IN CLINICALLY LOCALIZED PROSTATE CANCER?
18. EFFECTS OF SYSTEMATIC 12-CORE BIOPSY ON THE PERFORMANCE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR PROSTATE CANCER DETECTION
19. A Nomogram to Predict Seminal Vesicle Invasion by the Extent and Location of Cancer in Systematic Biopsy Results
20. Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors
21. Preoperative Plasma Soluble E-Cadherin Predicts Metastases to Lymph Nodes and Prognosis in Patients Undergoing Radical Cystectomy
22. PREOPERATIVE PLASMA LEVELS OF INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR PREDICT DISEASE RECURRENCE AND SURVIVAL OF PATIENTS WITH BLADDER CANCER
23. OPTIMAL COMBINATIONS OF SYSTEMATIC SEXTANT AND LATERALLY DIRECTED BIOPSIES FOR THE DETECTION OF PROSTATE CANCER
24. BILATERAL NERVE GRAFT DURING RADICAL RETROPUBIC PROSTATECTOMY: 1-YEAR FOLLOWUP
25. PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIAL
26. SILDENAFIL CITRATE AFTER RADICAL RETROPUBIC PROSTATECTOMY
27. MP27-14 CLINICAL EVALUATION AND TREATMENT OF NOCTURIA IS MODEST AT BEST
28. 2055 PROSTATE HEALTH INDEX (PHI) FOR REDUCING OVERDETECTION OF INDOLENT PROSTATE CANCER AND UNNECESSARY BIOPSY WHILE IMPROVING DETECTION OF AGGRESSIVE CANCERS
29. 651 COMPARATIVE ONCOLOGIC EFFECTIVENESS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY IN PATIENTS WITH EXTRACAPSULAR EXTENSION AND/OR SEMINAL VESICLE INVASION
30. 650 COMPARATIVE OUTCOME ANALYSIS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY MATCHED BY D'AMICO RISK CATEGORY
31. 982 EVALUATION OF THE PROSTATE HEALTH INDEX (PHI) IN THE 2 TO 4, AND 4 TO 10 NG/ML PSA RANGES: RESULTS FROM A MULTI-SITE, PROSPECTIVE, CLINICAL EVALUATION
32. 1207 BIOCHEMICAL FAILURE IN D'AMICO LOW RISK PATIENTS WITH GLEASON SUM UPGRADING FOLLOWING RADICAL PROSTATECTOMY: AN INTERNATIONAL, MULTI-INSTITUTIONAL STUDY
33. 350 OUTCOMES OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A MULTI-INSTITUTION STUDY ON 13,567 MEN
34. PRE-TREATMENT BIOMARKER LEVELS IMPROVE THE ACCURACY OF POST-PROSTATECTOMY NOMOGRAM FOR PREDICTION OF BIOCHEMICAL RECURRENCE
35. EARLY POSTOPERATIVE ULTRASENSITIVE PSA LEVEL PREDICTS RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
36. SERUM LEVELS OF BPSA EXHIBIT A TRANSIENT DRAMATIC “SPIKE” IN THE EARLY WEEKS AFTER INITIATION OF 5 ALPHA REDUCTASE THERAPY (5ARI)
37. IMPROVED PREDICTION OF DISEASE RELAPSE AFTER RADICAL PROSTATECTOMY USING A PANEL OF PREOPERATIVE BLOOD-BASED BIOMARKERS
38. 1433: Association of Blood Levels of Components of the Urokinase System of Plasminogen Activation with Prostate Cancer Presence, Invasion, Progression, and Metastasis
39. 1426: Pre-Operative Plasma Endoglin Levels Predict Metastasis to Lymph Nodes and Disease Progression in Patients Treated with Radical Prostatectomy
40. 1427: Circulating Levels of Plasminogen Activation Inhibitor-1 Improve the Accuracy of Pre- and Post-Operative Nomograms for Prediction of Prostate Cancer Recurrence after Radical Prostatectomy
41. 1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens
42. 1449: Up-Regulation of a Family of Interferon-Inducible Inflammatory Chemokines in Benign Prostatic Hyperplasia
43. 1363: Prediction of Prostate Volume Using Molecular forms of PSA in Men with BPH Enrolled on the GSK PHASE III Dutasteride Trials
44. 1352: Baseline Serum BPH-A Level Enhances the Accuracy of a Nomogram to Predict BPH Progression in Men Enrolled on the GSK Phase III Dutasteride Trials
45. 1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP)
46. 1164: The Influence of Increasing Experience and Surgical Technique on Surgical Margin Status in Patients Undergoing Open and Robotic Prostatectomy by a Single Surgeon
47. 1639: Development of a Nomogram to Predict Symptom Progression with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial
48. 1644: A Comparison of Men with a Four Point Increase - Confirmed or Not Confirmed in the AUA Symptom Score - Results from the MTOPS Study
49. 1640: Development of a Nomogram to Predict Acute Urinary Retention or BPH-Related Surgery with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial
50. 1638: Baseline Post Void Residual Urine Volume as a Predictor of Urinary Outcomes in Men with BPH in the MTOPS Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.